Navin Fluorine International Ltd.
NAVINFLUORCommodities filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
17 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 17 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20220801 | 2021-06-30 | yes | |
| TRANSCRIPT | 20220512 | 2022-03-31 | yes | |
| TRANSCRIPT | 20230213 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230517 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230804 | 2023-06-30 | yes | |
| TRANSCRIPT | 20231106 | 2023-09-30 | yes | |
| TRANSCRIPT | 20240213 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240513 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240805 | 2024-06-30 | yes | |
| TRANSCRIPT | 20241029 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250205 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250516 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250805 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251104 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260213 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260504 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260811 | 2026-06-30 | yes |
NAVINFLUOR
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 8,461.00 |
| 52-week range | 4552.2 – 8775.5 |
| Return 1M | 3.07% |
| Return 3M | 11.2% |
| Return 1Y | 82.75% |
| Return 3Y | 90.09% |
| Return 5Y | 116.92% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 1,045.00 |
| Other income | 35.00 |
| Total income | 1,080.00 |
| Cost of materials consumed | 442.00 |
| Purchases of stock-in-trade | 2.00 |
| Changes in inventories | 6.00 |
| Employee benefit expense | 87.00 |
| Finance costs | 32.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.27 | -0.00 |
| institutions foreign | 0.24 | -0.00 |
| institutions domestic | 0.28 | 0.01 |
| mutual funds | 0.21 | 0.03 |
| public | 0.73 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| TRANSCRIPT | 2026-06-30 | 17 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 419.00 | 564.00 | 697.00 | 491.00 | 472.00 | 502.00 | 602.00 | 524.00 | 519.00 | 606.00 | 701.00 | 725.00 | 758.00 | 892.00 | 938.00 | 1,045.00 |
| Other income | 11.00 | 10.00 | 4.00 | 8.00 | 23.00 | 12.00 | 13.00 | 10.00 | 11.00 | 10.00 | 12.00 | 14.00 | 18.00 | 16.00 | 18.00 | 35.00 |
| Total income | 430.00 | 574.00 | 701.00 | 499.00 | 495.00 | 514.00 | 614.00 | 534.00 | 530.00 | 617.00 | 713.00 | 739.00 | 777.00 | 908.00 | 955.00 | 1,080.00 |
| Cost of materials consumed | 203.00 | 267.00 | 248.00 | 221.00 | 185.00 | 228.00 | 270.00 | 218.00 | 235.00 | 289.00 | 306.00 | 307.00 | 297.00 | 359.00 | 425.00 | 442.00 |
| Purchases of stock-in-trade | 5.00 | 4.00 | 5.00 | 4.00 | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 3.00 | 4.00 | 2.00 | 1.00 | 3.00 | 2.00 |
| Changes in inventories | -25.00 | -25.00 | 31.00 | -22.00 | 14.00 | 2.00 | 30.00 | 10.00 | -13.00 | -27.00 | 13.00 | -3.00 | 13.00 | 7.00 | -39.00 | 6.00 |
| Employee benefit expense | 57.00 | 69.00 | 73.00 | 79.00 | 61.00 | 75.00 | 71.00 | 78.00 | 77.00 | 71.00 | 70.00 | 78.00 | 73.00 | 76.00 | 81.00 | 87.00 |
| Finance costs | 4.00 | 9.00 | 14.00 | 19.00 | 20.00 | 18.00 | 17.00 | 16.00 | 14.00 | 20.00 | 28.00 | 30.00 | 30.00 | 28.00 | 29.00 | 32.00 |
| Depreciation and amortisation | 18.00 | 25.00 | 8.00 | 21.00 | 24.00 | 25.00 | 26.00 | 27.00 | 28.00 | 30.00 | 35.00 | 35.00 | 37.00 | 36.00 | 41.00 | 42.00 |
| Other expenses | 85.00 | 93.00 | 139.00 | 95.00 | 111.00 | 120.00 | 120.00 | 115.00 | 110.00 | 124.00 | 131.00 | 133.00 | 126.00 | 141.00 | 147.00 | 152.00 |
| Total expenses | 347.00 | 442.00 | 517.00 | 418.00 | 418.00 | 469.00 | 535.00 | 466.00 | 453.00 | 509.00 | 586.00 | 584.00 | 579.00 | 649.00 | 687.00 | 762.00 |
| Profit before exceptional items and tax | 83.00 | 131.00 | 184.00 | 82.00 | 77.00 | 45.00 | 79.00 | 68.00 | 77.00 | 108.00 | 127.00 | 155.00 | 198.00 | 259.00 | 269.00 | 318.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -20.00 | 14.00 | 0.00 |
| Profit before tax | 83.00 | 131.00 | 184.00 | 82.00 | 77.00 | 97.00 | 79.00 | 68.00 | 77.00 | 108.00 | 127.00 | 155.00 | 198.00 | 238.00 | 282.00 | 318.00 |
| Current tax | 22.00 | 26.00 | 34.00 | 20.00 | 16.00 | 11.00 | -11.00 | 16.00 | 17.00 | 22.00 | 25.00 | 36.00 | 39.00 | 35.00 | 37.00 | 62.00 |
| Deferred tax | 3.00 | -1.00 | 14.00 | 0.00 | 1.00 | 8.00 | 20.00 | 1.00 | 1.00 | 2.00 | 7.00 | 2.00 | 10.00 | 18.00 | 32.00 | 13.00 |
| Tax expense | 25.00 | 25.00 | 48.00 | 20.00 | 17.00 | 19.00 | 9.00 | 17.00 | 18.00 | 24.00 | 32.00 | 38.00 | 49.00 | 53.00 | 70.00 | 75.00 |
| Profit for the period | 58.00 | 107.00 | 136.00 | 62.00 | 61.00 | 78.00 | 70.00 | 51.00 | 59.00 | 84.00 | 95.00 | 117.00 | 148.00 | 185.00 | 213.00 | 243.00 |
| Profit attributable to owners | 58.00 | 107.00 | 136.00 | 62.00 | 61.00 | — | 70.00 | — | — | — | 95.00 | 117.00 | 148.00 | 185.00 | 213.00 | 243.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other comprehensive income | -1.00 | 3.00 | 1.00 | 0.00 | 0.00 | 0.00 | -1.00 | 1.00 | 2.00 | -1.00 | 2.00 | 0.00 | -1.00 | 1.00 | 0.00 | 0.00 |
| Total comprehensive income | 57.00 | 109.00 | 138.00 | 62.00 | 61.00 | 78.00 | 70.00 | 52.00 | 60.00 | 82.00 | 97.00 | 118.00 | 148.00 | 186.00 | 213.00 | 244.00 |
| Earnings per share, basic | 11.67 | 21.50 | 27.51 | 12.41 | 12.22 | 15.74 | 14.20 | 10.33 | 11.86 | 16.86 | 19.15 | 23.63 | 29.06 | 36.18 | 41.49 | 47.45 |
| Earnings per share, diluted | 11.66 | 21.49 | 27.41 | 12.37 | 12.18 | 15.71 | 14.18 | 10.32 | 11.85 | 16.84 | 19.13 | 23.59 | 29.02 | 36.13 | 41.43 | 47.39 |
Annual results, as filed
| Line | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,062.00 | 1,179.00 | 1,453.00 | 2,077.00 | 2,065.00 | 2,349.00 | 3,314.00 |
| Other income | 33.00 | 79.00 | 39.00 | 36.00 | 56.00 | 44.00 | 65.00 |
| Total income | 1,095.00 | 1,258.00 | 1,493.00 | 2,113.00 | 2,121.00 | 2,393.00 | 3,379.00 |
| Cost of materials consumed | 496.00 | 528.00 | 650.00 | 906.00 | 902.00 | 1,048.00 | 1,388.00 |
| Purchases of stock-in-trade | 13.00 | 21.00 | 25.00 | 20.00 | 9.00 | 7.00 | 11.00 |
| Changes in inventories | -25.00 | -12.00 | -10.00 | -29.00 | 24.00 | -17.00 | -22.00 |
| Employee benefit expense | 131.00 | 142.00 | 182.00 | 249.00 | 286.00 | 297.00 | 307.00 |
| Finance costs | 2.00 | 2.00 | 2.00 | 28.00 | 75.00 | 78.00 | 118.00 |
| Depreciation and amortisation | 37.00 | 44.00 | 48.00 | 63.00 | 96.00 | 119.00 | 149.00 |
| Other expenses | 183.00 | 191.00 | 251.00 | 382.00 | 445.00 | 480.00 | 549.00 |
| Total expenses | 837.00 | 916.00 | 1,148.00 | 1,617.00 | 1,837.00 | 2,013.00 | 2,499.00 |
| Profit before exceptional items and tax | 258.00 | 342.00 | 344.00 | 496.00 | 283.00 | 380.00 | 880.00 |
| Exceptional items | 0.00 | 16.00 | 0.00 | 0.00 | 52.00 | 0.00 | -7.00 |
| Profit before tax | 258.00 | 358.00 | 344.00 | 496.00 | 336.00 | 380.00 | 873.00 |
| Current tax | -58.00 | 119.00 | 82.00 | 106.00 | 36.00 | 80.00 | 147.00 |
| Deferred tax | -85.00 | -9.00 | -1.00 | 15.00 | 29.00 | 11.00 | 62.00 |
| Tax expense | -144.00 | 111.00 | 81.00 | 121.00 | 65.00 | 91.00 | 210.00 |
| Profit for the period | 409.00 | 258.00 | 263.00 | 375.00 | 270.00 | 289.00 | 664.00 |
| Profit attributable to owners | 409.00 | 258.00 | 263.00 | 375.00 | 270.00 | 289.00 | 664.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other comprehensive income | 1.00 | 2.00 | -1.00 | 2.00 | 0.00 | 3.00 | 1.00 |
| Total comprehensive income | 409.00 | 260.00 | 262.00 | 377.00 | 271.00 | 291.00 | 665.00 |
| Earnings per share, basic | 82.60 | 52.03 | 53.12 | 75.70 | 54.57 | 58.20 | 130.67 |
| Earnings per share, diluted | 82.53 | 51.96 | 53.08 | 75.44 | 54.49 | 58.14 | 130.47 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 3,052.00 | 3,529.00 | 4,022.00 | 4,377.00 | 4,441.00 | 4,830.00 | 5,643.00 | 6,379.00 |
| Non-current assets | 1,711.00 | 2,063.00 | 2,578.00 | 2,824.00 | 3,017.00 | 3,242.00 | 3,533.00 | 3,594.00 |
| Current assets | 1,341.00 | 1,464.00 | 1,442.00 | 1,553.00 | 1,423.00 | 1,589.00 | 2,110.00 | 2,785.00 |
| Property, plant and equipment | 922.00 | 1,505.00 | 1,663.00 | 1,734.00 | 1,797.00 | 2,597.00 | 2,632.00 | 3,178.00 |
| Capital work-in-progress | 570.00 | 279.00 | 520.00 | 711.00 | 798.00 | 350.00 | 550.00 | 143.00 |
| Goodwill | 88.00 | 88.00 | 88.00 | 88.00 | 88.00 | 88.00 | 88.00 | 88.00 |
| Other intangible assets | 1.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 11.00 | 9.00 |
| Inventories | 348.00 | 468.00 | 429.00 | 372.00 | 361.00 | 322.00 | 358.00 | 446.00 |
| Trade receivables | 364.00 | 562.00 | 342.00 | 513.00 | 493.00 | 582.00 | 699.00 | 752.00 |
| Cash and cash equivalents | 15.00 | 14.00 | 8.00 | 7.00 | 9.00 | 20.00 | 49.00 | 23.00 |
| Total equity and liabilities | 3,052.00 | 3,529.00 | 4,022.00 | 4,377.00 | 4,441.00 | 4,830.00 | 5,643.00 | 6,379.00 |
| Equity | 1,945.00 | 2,185.00 | 2,266.00 | 2,383.00 | 2,470.00 | 2,626.00 | 3,601.00 | 3,975.00 |
| Equity share capital | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Other equity | 1,935.00 | 2,175.00 | 2,256.00 | 2,373.00 | 2,460.00 | 2,616.00 | 3,591.00 | 3,964.00 |
| Total liabilities | 1,107.00 | 1,344.00 | 1,756.00 | 1,994.00 | 1,971.00 | 2,204.00 | 2,042.00 | 2,405.00 |
| Non-current liabilities | 556.00 | 823.00 | 1,102.00 | 1,136.00 | 1,052.00 | 1,289.00 | 1,274.00 | 1,336.00 |
| Current liabilities | 551.00 | 521.00 | 625.00 | 858.00 | 919.00 | 915.00 | 768.00 | 1,068.00 |
| Borrowings, non-current | 500.00 | 753.00 | 1,024.00 | 1,023.00 | 939.00 | 1,053.00 | 949.00 | 940.00 |
| Borrowings, current | 94.00 | 96.00 | 214.00 | 317.00 | 419.00 | 387.00 | 195.00 | 286.00 |
| Trade payables | 185.00 | 243.00 | 197.00 | 302.00 | 243.00 | 327.00 | 392.00 | 529.00 |
Cash flow, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-03-31 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | -36.00 | -64.00 | 474.00 | 750.00 | 214.00 | 571.00 | 281.00 | 894.00 |
| Net cash from investing activities | -477.00 | -656.00 | -791.00 | -1,093.00 | -160.00 | -511.00 | -594.00 | -1,235.00 |
| Net cash from financing activities | 453.00 | 658.00 | 311.00 | 336.00 | -51.00 | -47.00 | 343.00 | 344.00 |
| Purchase of property, plant and equipment | 325.00 | 758.00 | 0.00 | 732.00 | 264.00 | 561.00 | 301.00 | 485.00 |
| Net increase in cash | -60.00 | -61.00 | -6.00 | -8.00 | 2.00 | 13.00 | 30.00 | 3.00 |
| con:CFO.BEFORE_TAX | 13.00 | 64.00 | 507.00 | 801.00 | 260.00 | 664.00 | 355.00 | 1,069.00 |
| con:INTEREST_RECEIVED.OPERATING | -2.00 | -3.00 | -2.00 | -3.00 | -1.00 | -2.00 | -2.00 | -3.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| con:TAX_PAID.OPERATING | 41.00 | 110.00 | 24.00 | 34.00 | 39.00 | 78.00 | 66.00 | 159.00 |
| con:CF_OTHER.OPERATING | -6.00 | -14.00 | -7.00 | -13.00 | -6.00 | -14.00 | -7.00 | -13.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:PPE_DISPOSALS | 2.00 | 2.00 | -396.00 | 54.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-07-11 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 28.81 | 28.81 | 28.81 | 28.81 | 28.80 | 28.44 | 28.44 | 28.44 | 28.01 | 27.14 | 0.27 | 0.27 | 0.27 | 0.27 |
| Domestic institutions | 25.97 | 26.02 | 28.92 | 28.61 | 27.41 | 28.18 | 28.46 | 30.04 | 28.71 | 29.88 | 0.30 | 0.28 | 0.28 | 0.28 |
| Mutual funds | — | — | — | — | — | — | — | — | 17.19 | 18.45 | 0.19 | 0.18 | 0.18 | 0.21 |
| Insurance companies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — |
| Foreign institutions | 18.50 | 19.20 | 15.92 | 15.57 | 18.02 | 18.23 | 18.55 | 20.16 | 21.55 | 21.98 | 0.22 | 0.24 | 0.24 | 0.24 |
| Government | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 71.19 | 71.19 | 71.19 | 71.19 | 71.20 | 71.56 | 71.56 | 71.56 | 71.99 | 72.86 | 0.73 | 0.73 | 0.73 | 0.73 |
| Non-institutional | 26.72 | 25.98 | 26.35 | 27.01 | 25.77 | 25.15 | 24.55 | 21.36 | 21.73 | 21.00 | 0.21 | 0.21 | 0.21 | 0.21 |
| Shares outstanding | 49562720 | 49562720 | 49563615 | 49564480 | 49574480 | 49580600 | 49581205 | 49581205 | 49582195 | 51184759 | 51222564 | 51233914 | 51240514 | 51283099 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Navin Fluorine Advanced Sciences Ltd., India | Wholly owned subsidiary | Any other transaction, Inter-corporate deposit, Inve | 30,066,500,000.00 | 13 |
| NFIL UK LTD.UK | Wholly owned subsidiary | Investment | 612,500,000.00 | 1 |
| Manchester Organics Ltd., UK | Wholly owned subsidiary | Investment | 326,500,000.00 | 1 |
| Sulakshana Securities Ltd, India | Wholly owned subsidiary | Any other transaction, Dividend received, Investment | 146,900,000.00 | 7 |
| Manchester Organics Limited | Wholly owned subsidiary | Any other transaction | 103,300,000.00 | 6 |
| Mr. Vishad P. Mafatlal | KMP | Any other transaction, Remuneration | 61,600,000.00 | 2 |
| NFIL USA INC, USA | Step down Subsidiary | Any other transaction | 51,800,000.00 | 1 |
| Non-Executive Directors | KMP | Any other transaction | 27,200,000.00 | 2 |
| Mr. Anish Ganatra | KMP | Remuneration | 22,500,000.00 | 1 |
| Mr. Nitin G. Kulkarni | KMP | Remuneration | 14,000,000.00 | 1 |
| Swarnim Gujarat Fluorspar Private Limited, India | Joint Venture | Investment | 11,800,000.00 | 1 |
| Mr. Niraj Mankad | KMP | Remuneration | 10,000,000.00 | 1 |
| Navin Fluorine Shanghai Co. Ltd., China | Wholly owned subsidiary | Any other transaction | 6,400,000.00 | 1 |
| Mr. Radhesh Welling | KMP | Any other transaction | 4,700,000.00 | 1 |
| Vigil Juris | Firm in which Independent Director | Any other transaction | 700,000.00 | 1 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-08-11 | Q1FY27 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2026-05-04 | Q4FY26 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2026-02-13 | Q3FY26 | FLUORINE INTERNATIONAL LIMITED, INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITE | Read the call |
| 2025-11-04 | Q2FY26 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2025-08-05 | Q1FY26 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2025-05-16 | FYFY25 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2025-02-05 | Q3FY25 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2024-10-29 | Q2FY25 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2024-08-05 | Q1FY25 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2024-05-13 | Q4FY24 | "! INTERNATIONAL LIMITED, "I INTERNATIONAL LI\HTED, FLUORINE INTERNATIONAL LIMITED, NAVIN | Read the call |
| 2024-02-13 | Q3FY24 | NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2023-11-06 | Q2FY24 | FLUORINE INTERNATIONAL LIMITED, NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2023-08-04 | Q1FY24 | NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2023-05-17 | Q4FY23 | NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2023-02-13 | Q3FY23 | Read the call | |
| 2022-08-01 | Q1FY22 | NAVIN FLUORINE INTERNATIONAL LIMITED | Read the call |
| 2022-05-12 | Q4FY22 | INTERNATIONAL LIMITED, \;,/ INTERNATIO'.'IAL LIMITED, \;,/ l'.'ITER1'ATIO'.'IALLIMITED | Read the call |
What they said about it, quarter by quarter
| Topic | Q3FY23 | Q3FY24 | Q3FY25 | Q3FY26 | Q4FY22 | Q4FY23 | Q4FY24 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | My second question is on the two new plants commenced. | Second, a capex of INR84 crores to enhance our HFC capacity, another 4,500 tons of R32 refrigerant gas which will be operational by Feb '25. | January 30, 2025 inflection point for the chemical sector to recover from here on with capex intensity, etcetera, picking on from these levels? | We are pleased to inform you that AHF project has been successfully commissioned during Q4 FY26. Additionally, the CAPEX for incremental HFC capacity … | And so, can you split up the CAPEX into what is for capacity and what is for maybe third-party sales? | May 13, 2023 Commercial production at 3 of our new plants, HPP, MPP and Agro-Intermediate plant has commenced successfully in the last fiscal. | Our capex of INR30 crores towards development of a completely new capability in Surat is on track and is expected to generate revenue from FY '25. | Our near-term priorities are efficient execution of announced capex and improving return ratios while scaling growth. |
| Capital allocation | — | — | — | — | So, the third piece will really help us in the long term because when typically, these customers get acquired, typically the acquisition happens at th… | We are pleased to inform you the Board of Directors have recommended a final dividend of INR7 per equity share of face value of INR2 each, subject to … | 2011 was when we actually made our entry into that by acquisition of the MOL business in U.K. And it's been an evolution from that, where we evolved. | I am glad to inform you that the Board in today's meeting has declared a final dividend of INR8.6 per equity share, 430% of the face value of INR2 per… |
| Costs | Now we are actually seeing some softening of the raw material, et cetera. | Last time when we met, we said that the peak revenue because of currency as well as higher raw material prices now stands at INR5.5 million. | — | So, there are input costs that are going higher. | But having said that, can you give us some perspective to what extent we would be able to protect ourselves against volatility in input costs? | — | — | But we've not had a situation where we've had to shut anything down for want of raw materials or anything like that. |
| Debt and cash | FY '24 debt should be of the order of about, say, on a consol basis, INR 1,300-odd crores, yes, which includes working capital and term debt and every… | Globally, unpredictable weather conditions, destocking of high-value inventory and cash flow management from ag majors has impacted the entire industr… | We continue to drive discipline in cost management, maximizing operational efficiency, generating robust cash flows and effectively managing risks to … | As of December 31, FY25, our net debt-to-equity ratio stood at 0.03x and net working capital was below 80 days of sales. | So, similarly, the working capital cycle would remain around the same level as it is currently. | Consolidated net cash flow from operations at negative INR63.6 crores primarily reflects initial working capital outlay following the start-up of comm… | In particular, for FY '24, the business generated operating cash flow delivery of INR750 crores aided by our continuous efforts on driving working cap… | Our net working capital days have improved to 74 days versus 90 days, reflecting a stronger operational efficiency and better conversion cycle. |
| Demand | The second point, which we had indicated earlier is that if you look at the calendar year '22, we had actually said that we are seeing a relatively so… | While the current order book for this segment continues to be built with efforts already done to strengthen and focus our business development team, w… | We remain optimistic about this segment, supported by strong order book for Q4 FY '25. | Our product pipeline continues to gain strength with scale-up in existing molecules and several new molecule launches are lined up. | But currently, what we see is that demand in the market for that rest of that volume is much higher than what we can supply, that is for the rest of t… | With this capacity, we will be prepared to address rising demand in the pharmaceutical and agrochemical sector as well as in the emerging areas like E… | Aggressive measures from inventory reduction by global Agchem majors, coupled with dumping by Chinese players have impacted the Agchem demand, albeit … | April 29, 2026 Our strong balance sheet continues to provide flexibility, while our robust order book across verticals underscore the confidence our c… |
| Guidance | And from January onwards, we expect that we will have full production -- we would have reached full capacity utilization for this dedicated plant. | We expect clarity on demand visibility by Q1 FY '25. | These priorities will guide us as we bring new projects online and continue to explore growth opportunities for the future. | We expect these to support our bilateral trade. | Given the volatility that has been seen on the raw material front in terms of costs and availability, can you guide us on how you have tried to protec… | Furthermore, we are excited to announce that the commissioning of R32 project in Surat is progressing as scheduled, and we anticipate commencing produ… | May 07, 2024 in sales for the end product, does that -- like -- do we assume ramp-up of that $100 million guidance or because that is a very large opp… | I would like to thank our customers for trusting us, our employees whose dedication has made every achievement possible, our Board for their continuou… |
| Margin | If you look at the margin, there is a slight impact of the product mix, but it's primarily driven by the volumes. | The sales in this quarter were impacted largely due to the following reasons: lower sales in CDMO segment, which is a higher- margin business vertical… | January 30, 2025 Our operating EBITDA for the last quarter has seen an increase of 95% Y-o-Y, achieving a sustainable EBITDA margin of 24.3%. | But any element of a quarter-specific contribution that whether we are seeing either in terms of revenue or in terms of margin? | Operating EBITDA margin stood at 25.3% as against 27.4% in the same period last year. | Operating EBITDA stood at INR550 crores as against INR355 crores in FY '22, up by 55%. | In the last fiscal, we have delivered revenues of INR2,065 crores and at an operating EBITDA of INR398 crores, underpinned by strong operating cash fl… | Thus particular number [inaudible 0:13:23] probably on the margin. |
| People | First, on the HFO side, now that we have reached the peak utilization, I wanted to understand more on the underlying product. | So what exactly is the capacity utilization of the multipurpose plant? | A key driver of this growth has been the increased capacity utilization at both our Dahej and Surat plant. | Where are we in the utilization cycle for all these projects? | — | Agrochemical Intermediate plant achieved optimal capacity utilization in the last quarter. | So with this 80% utilization that we mentioned, are all those four or five products being produced? | And we've always said that our endeavor would be to be around 50%, 60% capacity utilization this year. |
| Pricing | Also, we had last quarter alluded to the likelihood of some price hikes in the HPP product, the HFO product in the month of January, 15%, 20% perhaps. | Ref gas, in particular, R22 continues to face pricing pressure, especially in the international markets. | January 30, 2025 Now in the near term, we are going to see pricing pressure. | With continued positive pricing trends and ongoing capacity expansions, we are confident that the HPP business will continue to deliver sustainable gr… | The second point, the other project which is the MPP, that is a multi-product one, so that is a project where on some of the molecules, the principle … | So if you ask me from a, let's say, 2- to 3-year perspective, we believe that the pricing for R32, given the fact that our capacity is relatively limi… | As anticipated, we are witnessing positive trends in the domestic pricing of R32. | That means so necessitates the increased pricing to the contracts which we are working and spot prices probably adjust much faster, but how should we … |
| Revenue growth | And what is the growth at which this cash is growing as an industry? | For 9 months FY '24, on a consolidated basis, the company reported revenue from operations of INR1,465 crores as against INR1,380 crores in 9-month FY… | January 30, 2025 9-month performance, for 9 months FY '25 on a consolidated basis, the company reported net operating revenue of INR1,648 crores as ag… | Revenue for Q3 FY26 stood at INR412 crores, registering a 35% year-on-year growth, compared to INR306 crores in Q3 FY25. The growth was driven by comb… | 1,133 crore in FY21 delivering a growth of 24%. | We reported revenue growth of 28% on a Y-o-Y basis at INR204 crores for Q4 FY '23. | And going by the same cues, there were approximately four to five products, which would have contributed to that kind of a top line. | I'm pleased to share that we have reported a growth of more than 2x in EBITDA and PAT for the year. |
What they said they would do
Sentences in which management set an expectation. Each names the speaker and the page of the transcript it came from.
| Date | Quarter | Who | What they said |
|---|---|---|---|
| 2023-05-17 | Q4FY23 | NAVIN FLUORINE INTERNATIONAL LIMITED | Our revenue in Q4 FY '23 has doubled surpassing our stated guidance of approximately $10 million quarterly run rate on an annualized basis. |
| 2024-02-13 | Q3FY24 | NAVIN FLUORINE INTERNATIONAL LIMITED | However, approximately 3% to 4% of the margin impact is due to one-off fixed cost, deferral of specialty molecules and delayed stabilization of HFO plant, which we expect to recoup. |
| 2024-10-29 | Q2FY25 | NAVIN FLUORINE INTERNATIONAL LIMITED | Phase 1 involving an outlay of INR160 crores is progressing as planned, and we aim to have it commissioned by end of quarter 3 FY '26. |
| 2025-02-05 | Q3FY25 | NAVIN FLUORINE INTERNATIONAL LIMITED | January 30, 2025 Furthermore, we are making progress on our AHF project with an investment of INR450 crores, and the project is on track for commissioning by early FY '26. |
| 2025-05-16 | FYFY25 | NAVIN FLUORINE INTERNATIONAL LIMITED | Phase 1, which involves INR160 crores of investment is on track to be commissioned by end of quarter 3 FY '26. |